These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 11199947

  • 1. Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo.
    Romano S, Goodman W, Tamura R, Gonzales J.
    J Clin Psychopharmacol; 2001 Feb; 21(1):46-52. PubMed ID: 11199947
    [Abstract] [Full Text] [Related]

  • 2. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment.
    Romano SJ, Halmi KA, Sarkar NP, Koke SC, Lee JS.
    Am J Psychiatry; 2002 Jan; 159(1):96-102. PubMed ID: 11772696
    [Abstract] [Full Text] [Related]

  • 3. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder.
    Sayyah M, Boostani H, Pakseresht S, Malayeri A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar 17; 34(2):362-5. PubMed ID: 20035818
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.
    Amsterdam JD, Garcia-España F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Schweizer E, Beasley C.
    J Clin Psychopharmacol; 1998 Dec 17; 18(6):435-40. PubMed ID: 9864074
    [Abstract] [Full Text] [Related]

  • 5. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
    Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ.
    J Am Acad Child Adolesc Psychiatry; 1992 Nov 17; 31(6):1062-9. PubMed ID: 1429406
    [Abstract] [Full Text] [Related]

  • 6. Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder.
    Martenyi F, Brown EB, Zhang H, Koke SC, Prakash A.
    Br J Psychiatry; 2002 Oct 17; 181():315-20. PubMed ID: 12356658
    [Abstract] [Full Text] [Related]

  • 7. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
    Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT.
    J Clin Psychiatry; 2007 Aug 17; 68(8):1246-56. PubMed ID: 17854250
    [Abstract] [Full Text] [Related]

  • 8. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
    Tollefson GD, Birkett M, Koran L, Genduso L.
    J Clin Psychiatry; 1994 Oct 17; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.
    Amsterdam JD, Shults J.
    Am J Psychiatry; 2010 Jul 17; 167(7):792-800. PubMed ID: 20360317
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder.
    Koran LM, Hackett E, Rubin A, Wolkow R, Robinson D.
    Am J Psychiatry; 2002 Jan 17; 159(1):88-95. PubMed ID: 11772695
    [Abstract] [Full Text] [Related]

  • 18. Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.
    Reimherr FW, Amsterdam JD, Quitkin FM, Rosenbaum JF, Fava M, Zajecka J, Beasley CM, Michelson D, Roback P, Sundell K.
    Am J Psychiatry; 1998 Sep 17; 155(9):1247-53. PubMed ID: 9734550
    [Abstract] [Full Text] [Related]

  • 19. Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.
    Fineberg NA, Pampaloni I, Pallanti S, Ipser J, Stein DJ.
    Int Clin Psychopharmacol; 2007 Nov 17; 22(6):313-22. PubMed ID: 17917549
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.